Safety, Tolerability and Adherence With Rebif® New Formulation in Real Life Settings (STAR)

Clinical trial NCT01080027 · COMPLETED

Trial details

NCT number: NCT01080027
Sponsor: Merck KGaA, Darmstadt, Germany
Status: COMPLETED
Study type: OBSERVATIONAL

Multiple Sclerosis, Relapsing Remitting

Start date: 2008-10-01
Primary completion: 2011-06-01
Enrollment: 254

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.